Deliver a professional gastro-oesophageal reflux disease service through Scripter's structured consultation pathway. Supply: Esomeprazole 20 mg gastro-resistant tablets or capsules.

Book a demo Browse all PGDs

Illustration: Gastro-oesophageal reflux disease

What is Esomeprazole?

Esomeprazole is a proton pump inhibitor that switches off acid production in the stomach lining. A short course settles the heartburn and regurgitation of reflux disease, with the consultation screening for the alarm symptoms that need investigation rather than treatment.

The condition it treats

Gastro-oesophageal reflux disease is acid from the stomach washing back into the oesophagus, causing heartburn, an acid taste and sometimes cough or hoarseness. It is common and usually benign, but persistent or alarm symptoms need proper assessment.

How the service runs on Scripter

Patients book online, complete the pre-consultation questionnaire, and the guided pathway walks the practitioner through the gastro-oesophageal reflux disease consultation with the screening and counselling steps built in. The supply decision, the record and any GP notification are produced in the same flow, documented against the exact protocol version in force.

Training and eligibility requirements.

Who can deliver this service, and who it can be delivered to. The governing PGD document defines the definitive inclusion, exclusion and supply criteria; the Scripter consultation pathway enforces them, and every consultation is documented against the protocol version it ran under.

Practitioner training

✓Registered healthcare professional from a profession authorised to supply under PGDs (Schedule 16, Part 4 of the Human Medicines Regulations 2012), such as a pharmacist, nurse, paramedic or physiotherapist, with current registration with their professional regulator

✓Practising from premises suitable for the service, such as registered pharmacy premises or a registered clinic

✓Assessed clinical competency for this service, declared and reviewed as part of PGD authorisation

✓Sign-off against the current version of this PGD in Scripter before first supply; sign-offs expire automatically when the protocol is updated, and the platform notifies everyone affected

✓In-date basic life support and safeguarding training

✓Indemnity arrangements covering the service

Patient eligibility

✓Patients within the governing PGD's age range with typical reflux symptoms

✓Alarm features (weight loss, difficulty swallowing, bleeding, persistent vomiting, new symptoms over 55) referred rather than treated

✓Interactions and the duration limit set by the governing PGD applied

✓Lifestyle counselling and a review point agreed before repeat supply

Esomeprazole PGD questions

Omeprazole or esomeprazole?+

They are closely related; esomeprazole is the single-isomer form and some patients respond better to one than the other. The pathway supplies either within its limits.

How long should I take it?+

A short course of a few weeks, with review if symptoms return; long-term use should be reviewed by a prescriber.

When should I see a doctor instead?+

Difficulty swallowing, unintended weight loss, vomiting blood or black stools, or symptoms that persist despite treatment.

More reflux disease PGDs.

Related protocols in the same category, all delivered through the same platform.

Omeprazole

Gastro-oesophageal reflux disease (GORD)

View PGD

Run a gastro-oesophageal reflux disease service without the paperwork.

See the consultation pathway, the sign-off tracking and the record it produces in a free 30-minute demo.

Book a demo Contact us

Built for pharmacists, by pharmacists.